Cefoperazone Production Cost Reports

The report provides a detailed analysis essential for establishing a Cefoperazone manufacturing plant. It encompasses all critical aspects necessary for Cefoperazone production, including the cost of Cefoperazone production, Cefoperazone plant cost, Cefoperazone production costs, and the overall Cefoperazone manufacturing plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Cefoperazone production plant. These encompass manufacturing processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Cefoperazone is an antibiotic used to treat various bacterial infections such as respiratory tract infections, peritonitis and other intra-abdominal infections, bacterial septicemia, infections of the skin and skin structures, pelvic Inflammatory disease, endometritis, and other Infections of the female genital tract, enterococcal infections, and urinary tract infections. It is a member of the class of drugs called broad-spectrum cephalosporin antibiotics. Contrary to earlier cephalosporins, it exhibits broad-spectrum antibacterial action against Pseudomonas aeruginosa as well as other Gram-negative, Gram-positive, and anaerobic bacteria as well as Enterobacteriaceae.

The procurement of Cefoperazone is influenced by its utilization in the pharmaceutical and medical industries as an antibiotic used to treat various bacterial infections. The widespread occurrence of bacterial infections is significantly increasing the demand for Cefoperazone. Its ability to treat infections caused by both Gram-negative and Gram-positive aerobic bacteria amplifies its market presence. Its broad-spectrum usage allows it to be used for a wide range of infections, increasing its demand in healthcare settings. The availability of Cefoperazone for administration via intravenous or intramuscular injection makes it convenient for healthcare providers to use in various clinical settings, which contributes to its market expansion.

Its ability to be excreted through extrarenal mechanisms, unlike other cephalosporins, allows the drug to be used effectively in patients with renal impairment, expanding its potential patient population and driving market growth. Cefoperazone is generally well tolerated by patients and shows fewer side effects, which enhances patient adherence and significantly increases the market growth. Overall, industrial Cefoperazone procurement is influenced by its utilization in the pharmaceutical and medical industries, rising cases of bacterial infections, broad-spectrum usage, better tolerability, fewer side effects, extrarenal excretion, convenient dosing, patient compliance, and regulatory approvals.

Raw Material for Cefoperazone Production

According to the Cefoperazone manufacturing plant project report, the key raw material used in the production of Cefoperazone includes 4-ethylpiperazin-2,3-dion-1-carboxylic acid.

Manufacturing Process of Cefoperazone

The extensive Cefoperazone production cost report consists of the following major industrial manufacturing process:

• Production from 4-ethylpiperazin-2,3-dion-1-carboxylic acid: The manufacturing process of Cefoperazone starts with the reaction of the starting compound with 4-hydroxyphenylglycine to form α-(4-ethylpiperazin-2, 3-dion-1-carbonylamino)-4-hydroxyphenylacetic acid. The compound is reacted with ethyl chloroformate to form an anhydride. Finally, the anhydride undergoes acylation with acylating 7-amino-3-(1-methyl-1,2,3,4-tetrazol-5-yl)-thiomethyl-3-cefem-4-carboxylic acid to produce Cefoperazone.

Cefoperazone, commercially known as Cefobid, is a white to light brownish-yellow color having the molecular formula C25H27N9O8S2 and a molecular weight of 645.7 g/mol. It has a melting point in the range of 188-190 °C. It has a log P value of -0.74. It has an estimated water solubility of around 0.286 mg/mL. It is soluble in DMSO and methanol. Its predicted density is approximately 1.77 g/cm³. It must be stored at a temperature between 2-8 °C to keep it stable. It is a third-generation, broad-spectrum cephalosporin antibiotic used to treat various bacterial infections.